Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
Protocol summary
The number of developed follicles; number of oocytes obtained; number of embryos formed; number of clinical pregnancies
The number of developed follicles; number of oocytes obtained; number of embryos formed; number of clinical pregnancies, Number of preterm births, number of abortions, number of live births
The number of developed follicles; number of oocytes obtained; number of embryos formed; number of clinical pregnancies, Number of preterm births, number of abortions, number of live births
تعداد فولیکول های رشدیافته; تعداد تخمک های بدست آمده; تعداد جنین های تشکیل شده; تعداد حاملگی های کلینیکال
تعداد فولیکول های رشدیافته; تعداد تخمک های بدست آمده; تعداد جنین های تشکیل شده; تعداد حاملگی های کلینیکال، تعداد تولد پره ترم، تعداد سقط، تعداد تولد زنده
تعداد فولیکول های رشدیافته; تعداد تخمک های بدست آمده; تعداد جنین های تشکیل شده; تعداد حاملگی های کلینیکال، تعداد تولد پره ترم، تعداد سقط، تعداد تولد زنده
General information
Single blinded
Double blinded
singldoubl
1
1
50
70
5070
empty
Minor changes related to increasing the number of samples studied, increasing the number of outcomes studied
Minor changes related to increasing the number of samples studied, increasing the number of outcomes studied
empty
تغییرات جزیی مربوط به افزایش تعداد نمونه های مورد مطالعه، افزایش تعداد پیامدهای مورد بررسی
تغییرات جزیی مربوط به افزایش تعداد نمونه های مورد مطالعه، افزایش تعداد پیامدهای مورد بررسی
Women in the study are unaware of how they are grouped.
Women in the study and outcome assessors are unaware of how they are grouped.
Women in the study and outcome assessors are unaware of how they are grouped.
زنان شرکت کننده در مطالعه از نحوه گروه بندی مطلع نیستند.
زنان شرکت کننده در مطالعه و ارزیابان پیامدها از نحوه گروه بندی مطلع نیستند.
زنان شرکت کننده در مطالعه و ارزیابان پیامدها از نحوه گروه بندی مطلع نیستند.
Protocol summary
Study aim
The aim of this study is to determine the effect of Myo -inositol on fertility success in patients with IVF / ICSI cycles.
Design
In this single blinded randomized clinical trial, the researcher goes to the infertility clinic daily. Each patient who has inclusion criteria to enroll in the study is considered as a sample. Samples were divided into 2 groups A and B by computer random selection. Patients were randomly divided into two intervention and control groups based on randomized block method. Total of 50 patients were enrolled.
Settings and conduct
This clinical trial is carried out at the Infertility Clinic of Besat Hospital in Sanandaj. Patients are unaware of how they are grouped and blinded.
Participants/Inclusion and exclusion criteria
Inclusion criteria for the study included: Infertility for at least one year, not using contraception, candidates for IVF / ICSI, minimum age of 20 years and a maximum of 40 years, Agonist cycles.Exclusion criteria for the study included: Underlying disease, uterine Anomaly, freeze embryo transfer cycle, history of repeated abortions.
Intervention groups
Administration of 2000 mg myo-inositol plus 200 mg of folic acid daily to ICSI / IVF candidate patients referring to the Infertility Clinic of Besat Hospital with the onset of OCP since the onset of an agonist cycle or embryo transfer for 2 months.The control group received placebo with similar conditions in the same time .
Main outcome variables
The number of developed follicles; number of oocytes obtained; number of embryos formed; number of clinical pregnancies, Number of preterm births, number of abortions, number of live births
General information
Reason for update
Minor changes related to increasing the number of samples studied, increasing the number of outcomes studied
Acronym
IRCT registration information
IRCT registration number:IRCT20181225042109N1
Registration date:2019-05-09, 1398/02/19
Registration timing:prospective
Last update:2022-05-08, 1401/02/18
Update count:4
Registration date
2019-05-09, 1398/02/19
Registrant information
Name
Shahin Abbasi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 87 3366 4675
Email address
s.abbasi@muk.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2019-05-22, 1398/03/01
Expected recruitment end date
2019-09-21, 1398/06/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of Myo-inositol on pregnancy success in women with IVF/ICSI cycle
Public title
The effect of Myo-inositol on pregnancy success
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Infertility for at least one year
Not using contraception
Candidates for IVF / ICSI
Minimum age of 20 years and a maximum of 40 years
Agonist cycles
Exclusion criteria:
Underlying disease
Uterine Anomaly
Freeze embryo transfer cycle
History of repeated abortions
Age
From 20 years old to 40 years old
Gender
Female
Phase
3
Groups that have been masked
Participant
Outcome assessor
Sample size
Target sample size:
70
Randomization (investigator's opinion)
Randomized
Randomization description
The researcher goes to the clinic daily. Each patient who has inclusion criteria to enroll in the study is considered as a sample. Samples are divided into 2 groups A and B by computer random selection.Patients are randomly divided into two intervention and control groups based on randomized block method, for example: ABAB / AABB / BBAA.
Blinding (investigator's opinion)
Double blinded
Blinding description
Women in the study and outcome assessors are unaware of how they are grouped.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Kurdistan University of Medical Sciences
Street address
Pasdaran St., Kurdistan University of Medical Sciences
City
Sanandaj
Province
Kurdistan
Postal code
66177-13446
Approval date
2018-12-02, 1397/09/11
Ethics committee reference number
IR.MUK.REC.1397.236
Health conditions studied
1
Description of health condition studied
Female infertility
ICD-10 code
N97
ICD-10 code description
Female infertility
Primary outcomes
1
Description
Number of developed follicles
Timepoint
Two weeks after the intervention
Method of measurement
Using Sonography
2
Description
The number of oocytes obtained
Timepoint
Two weeks after the intervention
Method of measurement
Using Sonography
3
Description
Number of embryos formed
Timepoint
Third week after intervention
Method of measurement
Using Sonography
Secondary outcomes
1
Description
The number of clinical pregnancies
Timepoint
Third week after intervention
Method of measurement
Based on Beta-HCG and ultrasound confirmation
Intervention groups
1
Description
Intervention group: Administration of 2000 mg myo-inositol plus 200 mg of folic acid daily to ICSI / IVF candidate patients referring to the Infertility Clinic of Besat Hospital with the onset of OCP since the onset of an agonist cycle or embryo transfer for 2 months
Category
Treatment - Drugs
2
Description
Control group: Administration of placebo daily to ICSI / IVF candidate patients referring to the Infertility Clinic of Besat Hospital with the onset of OCP since the onset of an agonist cycle or embryo transfer for 2 months.
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Besat Hospital
Full name of responsible person
Shahin Abbasi
Street address
Keshavarz St, Besat Hospital, Sanandaj, Iran
City
Sanandaj
Province
Kurdistan
Postal code
66186-34683
Phone
+98 87 3328 5910
Email
s.abbasi@muk.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Sanandaj University of Medical Sciences
Full name of responsible person
Vice Chancellor for Research of Kurdistan University of Medical Sciences
Street address
Pasdaran St.,Kurdistan University of Medical Sciences, Sanandaj, Iran
City
Sanandaj
Province
Kurdistan
Postal code
66177-13446
Phone
+98 87 3366 4653
Email
Mozh.zarei@yahoo.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Sanandaj University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Sanandaj University of Medical Sciences
Full name of responsible person
Shahin Abbasi
Position
Resident of Obstetrics and Gynecology
Latest degree
Medical doctor
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Pasdaran St., Kurdistan University of Medical Sciences, Sanandaj, Iran
City
Sanandaj
Province
Kurdistan
Postal code
66177-13446
Phone
+98 87 3366 4673
Email
s.abbasi@muk.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Sanandaj University of Medical Sciences
Full name of responsible person
Fariba Seyedoshohadaie
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Keshavarz St, Besat Hospital, sanandaj, Iran
City
Sanandaj
Province
Kurdistan
Postal code
66177-13446
Phone
+98 87 3328 5910
Email
f.seyedoshohadaei@gmail.com
Person responsible for updating data
Contact
Name of organization / entity
Sanandaj University of Medical Sciences
Full name of responsible person
Shahin Abbasi
Position
Resident of Obstetrics and Gynecology
Latest degree
Medical doctor
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Pasdaran St., Kurdistan University of Medical Sciences, Sanandaj, Iran
City
Sanandaj
Province
Kurdistan
Postal code
66177-13446
Phone
+98 87 3366 4673
Email
s.abbasi@muk.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Not applicable
Title and more details about the data/document
Part of the data on the primary outcome is for sharing.
When the data will become available and for how long
One year after the publication the data will be available.
To whom data/document is available
Researchers working in academic and scientific institutions.
Under which criteria data/document could be used
Meta-analysis is allowed on the data of this study.
From where data/document is obtainable
Dr. Shahin Abbasi, Pasdaran St., Kurdistan University of Medical Sciences, Sanandaj, Iran,Email: s.abbasi@muk.ac.ir
What processes are involved for a request to access data/document
After one year of publishing the article and publishing the results, those who need the data of this study, could apply via email .